MARKET

IONS

IONS

Ionis Pharmaceuticals
NASDAQ
79.45
+0.79
+1.00%
After Hours: 79.96 +0.51 +0.64% 19:27 03/04 EST
OPEN
79.16
PREV CLOSE
78.66
HIGH
80.07
LOW
77.67
VOLUME
2.50M
TURNOVER
--
52 WEEK HIGH
86.74
52 WEEK LOW
23.95
MARKET CAP
13.12B
P/E (TTM)
-33.3333
1D
5D
1M
3M
1Y
5Y
1D
Ionis Pharmaceuticals Is Maintained at Outperform by Leerink Partners
Dow Jones · 1d ago
Ionis Pharmaceuticals Price Target Raised to $104.00/Share From $102.00 by Leerink Partners
Dow Jones · 1d ago
Leerink Partners Maintains Outperform on Ionis Pharmaceuticals, Raises Price Target to $104
Benzinga · 1d ago
Cathie Wood's weekly recap: adds defense stock Kratos, CoreWeave, Baidu
Seeking Alpha · 2d ago
Ionis Pharmaceuticals (IONS) Receives a Buy from H.C. Wainwright
TipRanks · 3d ago
Weekly Report: what happened at IONS last week (0223-0227)?
Weekly Report · 3d ago
FDA Priority Review And 2026 Outlook Might Change The Case For Investing In Ionis (IONS)
Simply Wall St · 3d ago
Ionis FDA And Phase 3 Updates Reframe Rare Disease Valuation Story
Simply Wall St · 4d ago
More
About IONS
Ionis Pharmaceuticals, Inc. develops six marketed medicines for serious diseases, including medicines for neurologic and cardiovascular diseases. Its marketed medicines consist of TRYNGOLZA, WAINUA (eplontersen), SPINRAZA (nusinersen), QALSODY (tofersen), TEGSEDI (inotersen) and WAYLIVRA (volanesorsen). TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS). WAINUA is approved for the treatment of the polyneuropathy of hereditary transthyretin-medicated amyloidosis (ATTRv-PN) in adults. SPINRAZA is used for the treatment of pediatric and adult patients with spinal muscular atrophy. QALSODY is approved for the treatment of Amyotrophic Lateral Sclerosis in adults who have a mutation in the superoxide dismutase 1 (SOD1) gene, or SOD1-ALS. TEGSEDI is approved for the treatment of ATTRv-PN in adults. WAYLIVRA is approved as an adjunct to diet in adult patients with genetically confirmed FCS and at high risk of acute, potentially fatal pancreatitis.

Webull offers Ionis Pharmaceuticals Inc stock information, including NASDAQ: IONS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IONS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IONS stock methods without spending real money on the virtual paper trading platform.